XM
BLUE

XTX Markets’s bluebird bio BLUE Stock Holding History

XTX Markets’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$248K Buy
+442
New +$280K 0.51% 82

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

XTX Markets's BLUE Position: Q4 2020 in Review

XTX Markets opened a new position in bluebird bio (BLUE) in Q4 2020: 442 shares worth $248K. The stake represents 0.51% of the portfolio and ranks #82 among its holdings.

262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • XTX Markets held 442 shares of bluebird bio worth $248K as of Q4 2020.
  • bluebird bio was a new XTX Markets position in Q4 2020.
  • bluebird bio made up 0.51% of XTX Markets's portfolio in Q4 2020, its #82 holding.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.